ACR适宜性标准®肝癌管理:2022年更新
该文件为ACR适宜性标准2022年更新,针对肝脏恶性肿瘤(原发与转移)的多种局部和全身治疗选择,基于9个临床场景评估经皮消融、单纯栓塞、经动脉化疗栓塞(TACE)和经动脉放射栓塞(TARE)等介入治疗的适宜性。指南采用GRADE和RAND/UCLA适宜性方法,由多学科专家小组每年审查证据制定推荐。
要点
- 介入放射科医生在多种肝脏定向治疗中起关键作用,包括经皮消融、单纯颗粒栓塞、TACE和TARE。
- 本文件基于9个临床场景描述每种治疗方法的适宜性。
- ACR适宜性标准为循证指南,由多学科专家小组每年审查,采用GRADE和RAND/UCLA适宜性方法评估证据。
核心结论
- 基于9个临床场景,本文件描述了经皮消融、单纯栓塞、TACE和TARE等肝脏定向治疗各自的适宜性。
- 介入放射科医生在提供多种肝脏定向治疗中发挥关键作用。
研究设计与样本
- ACR适宜性标准为针对特定临床情况的循证指南,由多学科专家小组每年审查。
- 指南制定与修订过程支持对同行评审期刊医学文献的系统分析。
- 采用GRADE等既定方法学原则评估证据。
- 采用RAND/UCLA适宜性方法用户手册确定特定临床场景下影像和治疗程序的适宜性。
- 当同行评审文献缺乏或模棱两可时,专家可能是制定推荐的主要证据来源。
诊断标准与关键数值
- 基于9个临床场景评估经皮消融、单纯栓塞、TACE和TARE等治疗的适宜性。
- 采用GRADE评估证据,采用RAND/UCLA适宜性方法确定适宜性。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 当同行评审文献缺乏或模棱两可时,专家可能是制定推荐的主要证据来源。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The treatment and management of hepatic malignancies can be complex because it encompasses a variety of primary and metastatic malignancies and an assortment of local and systemic treatment options. When to use each of these treatments is critical to ensure the most appropriate care for patients. Interventional radiologists have a key role to play in the delivery of a variety of liver directed treatments including percutaneous ablation, transarterial embolization with bland embolic particles alone, transarterial chemoembolization (TACE) with injection of a chemotherapeutic emulsion, and transarterial radioembolization (TARE). Based on 9 clinical variants, the appropriateness of each treatment is described in this document. The ACR Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances in which peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.
引用
- Knavel Koepsel EM, Smolock AR, Pinchot JW, et al. ACR Appropriateness Criteria® Management of Liver Cancer: 2022 Update. J Am Coll Radiol. 2022. PMID: 36436965. doi:10.1016/j.jacr.2022.09.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。